Search

everythinglearnresearchcommunity

for

Search:↓

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

JAK inhibitors show promise for treating various skin diseases.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Botulinum Toxin A may help with hair growth and has some side effects; more research is needed.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

The patient's hair loss from alopecia totalis returned despite initial successful treatment.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Hair follicles can be used to quickly assess drug effects in cancer treatment.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

α-mangostin nanoparticles improved acne with minimal irritation.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

Minoxidil nanoparticles can potentially be a more effective treatment for hair growth than current treatments.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

New treatments like nanotechnology show promise in improving skin cancer therapy.